Angelo Morini

Entrepreneur - Second Time Founder - Angel Investor

📍 Italy🔄 Updated July 2026💼 2 investments📅 4 years investing🗓 Last invested Dec 2023
Operator-angel🌍 Italy
2
Total investments
0
Early stage
0
Mid stage
0
Late stage
4y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor and Board member
Dec 2023
Medendi gives patients a deep understanding of their specific tumor profile and identifies and advises the most effective targeted treatment options available, including worldwide clinical trials, when appropriate. The Medendi process is totally online, paperless, and quick. In one month from on boarding the patient will be advised with the best available treatment options, provided by the most qualified health structures network. The Journey. Analysis: an expert, from the Medendi Scientific Committee, analyzes the patient’s clinical documentation and evaluates whether genomic profiling is needed or, alternatively, the patient would benefit from a second opinion. Genetic Testing: to identify the best available treatment, the tumor is profiled with the most advanced genetic tests to scan for tumor genomic alterations. Recommendation: the expert advises the patient with the best therapeutic options available worldwide, including molecules and drugs in clinical trial; Medendi, thanks to its global network and online DBs, is up to date with the most qualified medical centers, the new drugs and molecules researched and the ongoing clinical trials. Treatment: Medendi supports the patients in the therapy phase: accessing the selected medical center and the best specialists, providing the most appropriate treatment, managing documentation, and eventually supporting the patient and the family for trip and accommodation.
Experience · 6 entries
All (6)
Investments (2)
Founder (4)
Board (1)
2023
Investor and Board member
Dec 2023
Medendi gives patients a deep understanding of their specific tumor profile and identifies and advises the most effective targeted treatment options available, including worldwide clinical trials, when appropriate. The Medendi process is totally online, paperless, and quick. In one month from on boarding the patient will be advised with the best available treatment options, provided by the most qualified health structures network. The Journey. Analysis: an expert, from the Medendi Scientific Committee, analyzes the patient’s clinical documentation and evaluates whether genomic profiling is needed or, alternatively, the patient would benefit from a second opinion. Genetic Testing: to identify the best available treatment, the tumor is profiled with the most advanced genetic tests to scan for tumor genomic alterations. Recommendation: the expert advises the patient with the best therapeutic options available worldwide, including molecules and drugs in clinical trial; Medendi, thanks to its global network and online DBs, is up to date with the most qualified medical centers, the new drugs and molecules researched and the ongoing clinical trials. Treatment: Medendi supports the patients in the therapy phase: accessing the selected medical center and the best specialists, providing the most appropriate treatment, managing documentation, and eventually supporting the patient and the family for trip and accommodation.
Founder & CEO
Jul 2023
BIONSEEK is an innovative startup focused on advanced research in the field of biotechnology sciences, with the aim of developing innovative personalized diagnostics and therapies for cancer patients.
2022
Business Angel
Dec 2022
Italian Angels for Growth (IAG) is the leading Network-Powered Venture Capital investor in Italy: more than 600 business angels from the entrepreneurial, financial, and industrial worlds have come through the IAG network, investing time, expertise, and capital for the growth of innovative startups. Among the first Italian investors in the early stage, IAG, in sixteen years of activity, has analyzed more than 7,000 investment opportunities and closed more than 125 deals, for a total of more than 550 million euros invested by IAG members and its co-investors, which have generated +1100 jobs and 310 million in generated revenues, creating an ecosystem involving more than 150 national and international partners. Four operating offices: Milan, Rome, Florence and Udine. info@italianangels.net
Founder & CEO
Jun 2022
EGAVÌ è un nuovo brand nel settore Biotech, con l’obiettivo di sviluppare nuove ed innovative terapie/prodotti, caratterizzati dallacqua Sulfurea/Alcalina della nostra Sorgente Naturale BAD PEDRACES in Alta Badia, finalizzati alla cura sistemica di patologie dermatologiche acute, problematiche respiratorie e muscolo scheletriche.
2019
Co-Founder
Apr 2019
We create technology with a purpose: to make HRs work smoother, easier and more valuable by automating human resource management tasks.
 bValue is a software that helps HR reps, managers and the entire business population of SMEs to recruit, manage and develop people in one simple and intuitive platform. 
 bValue measures the entire professional life cycle of employees, from Recruiting to Off-Boarding, generating and grouping data in the form of KPIs in dedicated reports and dashboards, ready for one-click extraction. Visit www.bvaluehr.com to find out more.
Show all 6 entries ↓